Current：Home > ScamsEli Lilly says an experimental drug slows Alzheimer's worsening -Wealth Momentum Network
Eli Lilly says an experimental drug slows Alzheimer's worsening
View
Date：2025-04-18 03:19:10
WASHINGTON — Eli Lilly and Co. said Wednesday its experimental Alzheimer's drug appeared to slow worsening of the mind-robbing disease in a large study.
In the 18-month trial, people in the early stages of Alzheimer's who received infusions of donanemab showed 35% less decline in thinking skills compared to those given a dummy drug, Lilly announced in a press release.
The drug is designed to target and clear away a sticky protein called beta-amyloid that builds up into brain-clogging plaques that are one hallmark of Alzheimer's.
A similar amyloid-targeting drug, Eisai and Biogen's Leqembi, recently hit the market with similar evidence that it could modestly slow Alzheimer's — and also some safety concerns, brain swelling or small brain bleeds.
Donanemab also comes with that risk. Lilly said in its study, the brain side effects caused the deaths of two participants and a third also died after a serious case.
The preliminary study results haven't been vetted by outside experts. Indianapolis-based Lilly plans to release more details at an international Alzheimer's meeting this summer and is seeking Food and Drug Administration approval of the drug.
veryGood！ (3853)
Related
- Trump wants to turn the clock on daylight saving time
- New York governor blocks discharge of radioactive water into Hudson River from closed nuclear plant
- The U.S. imports most of its solar panels. A new ruling may make that more expensive
- Clashes erupt between militias in Libya, leaving dozens dead
- Federal Spending Freeze Could Have Widespread Impact on Environment, Emergency Management
- American Airlines sues a travel site to crack down on consumers who use this trick to save money
- Top 10 deadliest hurricanes in U.S. history
- Pentagon review finds structural changes needed at military service academies to address sexual harassment
- Why members of two of EPA's influential science advisory committees were let go
- 9 California officers charged in federal corruption case
Ranking
- Tarte Shape Tape Concealer Sells Once Every 4 Seconds: Get 50% Off Before It's Gone
- What Jessica Simpson and Nick Lachey's Marriage Was Like on Newlyweds—and in Real Life
- Company that leaked radioactive material will build barrier to keep it away from Mississippi River
- Wisconsin Republicans propose eliminating work permits for 14- and 15-year-olds
- Hackers hit Rhode Island benefits system in major cyberattack. Personal data could be released soon
- Jethro Tull leader is just fine without a Rock Hall nod: 'It’s best that they don’t ask me'
- Maryland reports locally acquired malaria case for first time in more than 40 years
- 'Deep, dark, rich and complex': Maker's Mark to release first old bourbon in 70-year history
Recommendation
A Mississippi company is sentenced for mislabeling cheap seafood as premium local fish
Conspiracy theorists gather at Missouri summit to discuss rigged voting machines, 2020 election
Pentagon review finds structural changes needed at military service academies to address sexual harassment
Jethro Tull leader is just fine without a Rock Hall nod: 'It’s best that they don’t ask me'
Alex Murdaugh’s murder appeal cites biased clerk and prejudicial evidence
DonorsChoose sees banner donation year with help from Gates Foundation and millions of small gifts
FEMA has paid out nearly $4 million to Maui survivors, a figure expected to grow significantly
Blue Shield of California opts for Amazon, Mark Cuban drug company in switchup